RAND's divisions conduct research on a uniquely broad front for clients around the globe.
Most relevant regions
Project
Apr 9, 2025
RAND Europe and the University of Cambridge are evaluating the FIT@80 pilot to lower the screening threshold for bowel cancer.
Research
Jan 21, 2025
This paper evaluates the cost-effectiveness of and outcomes associated with noninvasive colorectal cancer screening strategies, including new blood-based tests, in a population with low adherence to screening.
Dec 30, 2024
We analyzed incidence rates of rectal, distal colon, and proximal colon cancer for individuals aged 20 years or more for diagnosis years 1978-2017 using 2-stage generalized linear models to determine age, period, and cohort effects for CRC incidence.
Nov 4, 2024
Effective communication of treatment side effects (SE) is critical for shared decision-making (SDM) in localized prostate cancer. This article qualitatively characterizes how physicians communicate SE in consultations.
Physician treatment preference may influence how risks are communicated in prostate cancer consultations. We identified persuasive language use when describing cancer prognosis, life expectancy, and side effects.
Sep 25, 2024
Our qualitative findings show how practitioners in cancer prevention and control build strong community partnerships and make changes in health care and public health settings to advance health equity.
Sep 9, 2024
The contribution of medical mistrust to healthcare utilization delays has been gaining increasing attention. This study assesses how medical mistrust affects prostate cancer screening behavior among groups of Black men.
Aug 12, 2024
Global guidelines for cervical cancer screening leave many implementation decisions at countries’ discretion. Using a Markov model, we estimate the relative health outcomes and costs of different approaches to cervical cancer screening in Malawi.
Jun 17, 2024
Identifies test performance and cost benchmarks that would make blood-based colorectal cancer screening as effective and cost-effective as established alternatives.
This paper demonstrates the use of artificial neural network emulators to enable Bayesian calibration of cancer microsimulation models.
Jun 12, 2024
Our report provides a guide on how to develop robust, fit for purpose diagnostic Target Product Profiles (TPPs) for cancer, and support efforts to improve on earlier cancer detection.
Jun 10, 2024
RAND Europe’s work is helping understand how diagnostic Target Product Profiles for cancer can be developed and the types of features they need to cover to be useful for innovators, payers and ultimately healthcare professionals and patients.
